NDC 81033-032-01 - Mupirocin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-032
- Requested NDC
- 81033-032-01
- Package NDCs from labels
- 81033-032-01, 81033-032-50, 81033-032-99
- Manufacturer
- Kesin Pharma Corporation
- Effective date
- 2025-05-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Mupirocin Ointment - Kesin Pharma Corporation | Kesin Pharma Corporation | 2025-05-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-032-01 | Mupirocin | 1 g in 1 TUBE | OINTMENT | 1 | 7 | |
| 81033-032-50 | Mupirocin | 50 in 1 BOX | OINTMENT | 50 | 7 | |
| 81033-032-99 | Mupirocin | 100 in 1 BOX | OINTMENT | 100 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-032-01 | GM - Gram | 81033-032 | bee79b6e-6f9e-40d7-861f-6b07462600b9 | 1 | 2025-06-13 |
| 81033-032-50 | GM - Gram | 81033-032 | c06a73cb-4436-4d1a-a85d-c11b32f9f744 | 1 | 2025-06-13 |
| 81033-032-99 | GM - Gram | 81033-032 | 72584aad-1ebd-45d0-a738-c191d702f88f | 1 | 2025-06-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dry eye relief | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | CARDINAL HEALTH 110, LLC. DBA LEADER | f8da3af5-9172-4023-be82-0fd5bd891616 | 2025-09-12 | Warnings | B697894SGQ |
| GAVILYTE-N | POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE | Lupin Pharmaceuticals,Inc. | 27195187-75a3-431f-90d9-84da1b94e849 | 2025-09-10 | Warnings, Adverse reactions | G2M7P15E5P |
| GaviLyte - C TM | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES WITH FLAVOR PACK | Lupin Pharmaceuticals,Inc. | a8b15625-ca7c-4d57-9f36-3ac2a6d13665 | 2025-09-10 | Warnings, Adverse reactions | G2M7P15E5P |
| GAVILYTE G TM | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Lupin Pharmaceuticals,Inc. | 3978822b-6473-4072-9f80-20ceb9bea355 | 2025-09-10 | Warnings, Adverse reactions | G2M7P15E5P |
| Polyethylene Glycol 3350 and electrolytes - Unflavored | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES - UNFLAVORED | Strides Pharma Science Limited | 48c741a9-9039-4fdb-a875-86d4ea968282 | 2025-09-05 | Warnings, Adverse reactions | G2M7P15E5P |
| Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride - Unflavored | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE - UNFLAVORED | Strides Pharma Science Limited | 37c111ec-5b62-42b9-bbb2-3b0c530e34c9 | 2025-09-01 | Warnings, Adverse reactions | G2M7P15E5P |
| clearlax | POLYETHYLENE GLYCOL 3350 | Meijer, Inc. | 8cca18a8-94f6-43f6-bdb7-2d44a6cdf151 | 2025-08-08 | Warnings | G2M7P15E5P |
| Systane Ultra | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 0537c23a-15f7-be64-1231-a6c93468e9a8 | 2025-07-30 | Warnings | B697894SGQ |
| Systane | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 1d679d0f-cec2-a644-79cd-079607254bb9 | 2025-07-30 | Warnings | B697894SGQ |
| Systane Ultra Preservative Free | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 751fb85f-6683-4b0a-a650-324d4a74c5de | 2025-07-30 | Warnings | B697894SGQ |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | ATLANTIC BIOLOGICALS CORP. | c9688f06-b6db-4afb-b8ff-ef5fb8bf9946 | 2025-07-22 | Warnings | G2M7P15E5P |
| Mupirocin | MUPIROCIN | Sun Pharmaceutical Industries, Inc. | 900bb675-2f03-47e3-854e-257ec4831332 | 2025-07-07 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| Visine Red Eye Hydrating Comfort Eye Drops | TETRAHYDROZOLINE HYDROCHLORIDE AND POLYETHYLENE GLYCOL 400 | Morning Star OTC | dcd4164c-aa1e-4f07-ab2c-b439275629db | 2025-06-16 | Warnings | B697894SGQ |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Kesin Pharma Corporation | 3729a1d2-4c98-dfdf-e063-6394a90a5a87 | 2025-06-12 | Warnings | G2M7P15E5P |
| CLEARLAX | POLYETHYLENE GLYCOL 3350 | STRATEGIC SOURCING SERVICES LLC | 041157b8-476c-e7d2-e063-6394a90ac3a0 | 2025-06-11 | Warnings | G2M7P15E5P |
| mupirocin | MUPIROCIN | ATLANTIC BIOLOGICALS CORP. | da2f7d4e-82c6-4790-8eea-3a97e5b30734 | 2025-05-28 | Warnings, Adverse reactions | ANDA065123 106346 D0GX863OA5 |
| Mupirocin | MUPIROCIN OINTMENT | Kesin Pharma Corporation | b8e115ce-c8ff-4d08-b865-71dc4d0e51a1 | 2025-05-28 | Warnings, Adverse reactions | ANDA065123 81033-032-50 81033-020-01 81033-020-50 81033-020-99 81033-032-01 81033-032-99 81033-020 81033-032 81033003201 106346 36357344-6528-ef04-e063-6394a90a8fa9 b8e115ce-c8ff-4d08-b865-71dc4d0e51a1 D0GX863OA5 |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | SKY Packaging | 173a62cb-9b20-4b50-e063-6294a90ac36b | 2025-05-14 | Warnings | G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Camber Consumer Care Inc | b321a7f5-f80b-4a51-9fd9-2c21fc1cae9b | 2025-04-23 | Warnings | G2M7P15E5P |
| good neighbor pharmacy clearlax | POLYETHYLENE GLYCOL 3350 | Amerisource Bergen | e0b419b6-6ce0-4aaa-948f-dee5b2ec2082 | 2025-04-17 | Warnings | G2M7P15E5P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.